CONDENSED TRYCICLIC PYRROLES AS ALPHA-1 ANTITRYPSIN MODULATORS

The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I), tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated deriva...

Full description

Saved in:
Bibliographic Details
Main Authors GAGNON, Kevin James, LOOKER, Adam, BOYD, Michael John, ZAKY, Mariam, GARCIA BARRANTES, Pedro Manuel, FLEMING, Gabrielle Simone, RODAY, Setu, GIACOMETTI, Robert Daniel, JOHNSON, JR, FANNING, Lev Tyler Dewey, RONKIN, Steven M, STAVROPOULOS, Kathy, KESAVAN, Sarathy, THOMSON, Stephen, JONES, Peter, SAWANT, Rupa, GUIDO, Samantha, HOOD, Sarah Carol, SWETT, Rebecca Jane, NUHANT, Philippe Marcel, SHI, Yi, SHRESTHA, Muna, MAXWELL, Brad, BOUCHER, Diane, SPOSATO, Marisa, GREY JR., Ronald Lee, BRODNEY, Michael Aaron, MEDEK, Ales, BLIGH, Cavan McKeon, OVERHOFF, Kirk Alan, HURLEY, Dennis James, CLARK, Michael Philip, MAXWELL, John Patrick, DAMAGNEZ, Veronique, XU, Jinwang, FIMOGNARI, Robert Francis, LAI, Mei-Hsiu, BANDARAGE, Upul Keerthi, HALL, Amy Beth, TAPLEY, Timothy Lewis, ROEPER, Stefanie, LIU, Siying, GIROUX, Simon, TANG, Qing
Format Patent
LanguageEnglish
French
Published 10.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I), tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds. L'invention concerne des composés utiles pour traiter une déficience en alpha-1 antitrypsine (AATD), selon la formule (I), des tautomères de ceux-ci, des sels pharmaceutiquement acceptables des composés, des sels pharmaceutiquement acceptables des tautomères, des dérivés deutérés des composés, des dérivés deutérés des tautomères, et des dérivés deutérés des sels, des formes solides de ces composés et des procédés de fabrication de ces composés.
AbstractList The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I), tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds. L'invention concerne des composés utiles pour traiter une déficience en alpha-1 antitrypsine (AATD), selon la formule (I), des tautomères de ceux-ci, des sels pharmaceutiquement acceptables des composés, des sels pharmaceutiquement acceptables des tautomères, des dérivés deutérés des composés, des dérivés deutérés des tautomères, et des dérivés deutérés des sels, des formes solides de ces composés et des procédés de fabrication de ces composés.
Author GIACOMETTI, Robert Daniel
LOOKER, Adam
SAWANT, Rupa
JONES, Peter
ROEPER, Stefanie
SWETT, Rebecca Jane
LIU, Siying
RODAY, Setu
SHRESTHA, Muna
XU, Jinwang
FIMOGNARI, Robert Francis
GUIDO, Samantha
GREY JR., Ronald Lee
HALL, Amy Beth
FANNING, Lev Tyler Dewey
GAGNON, Kevin James
GIROUX, Simon
TAPLEY, Timothy Lewis
OVERHOFF, Kirk Alan
FLEMING, Gabrielle Simone
MAXWELL, John Patrick
RONKIN, Steven M
ZAKY, Mariam
MEDEK, Ales
GARCIA BARRANTES, Pedro Manuel
SHI, Yi
NUHANT, Philippe Marcel
HOOD, Sarah Carol
HURLEY, Dennis James
LAI, Mei-Hsiu
TANG, Qing
SPOSATO, Marisa
MAXWELL, Brad
CLARK, Michael Philip
KESAVAN, Sarathy
THOMSON, Stephen
BOUCHER, Diane
BANDARAGE, Upul Keerthi
BLIGH, Cavan McKeon
JOHNSON, JR
DAMAGNEZ, Veronique
BRODNEY, Michael Aaron
STAVROPOULOS, Kathy
BOYD, Michael John
Author_xml – fullname: GAGNON, Kevin James
– fullname: LOOKER, Adam
– fullname: BOYD, Michael John
– fullname: ZAKY, Mariam
– fullname: GARCIA BARRANTES, Pedro Manuel
– fullname: FLEMING, Gabrielle Simone
– fullname: RODAY, Setu
– fullname: GIACOMETTI, Robert Daniel
– fullname: JOHNSON, JR
– fullname: FANNING, Lev Tyler Dewey
– fullname: RONKIN, Steven M
– fullname: STAVROPOULOS, Kathy
– fullname: KESAVAN, Sarathy
– fullname: THOMSON, Stephen
– fullname: JONES, Peter
– fullname: SAWANT, Rupa
– fullname: GUIDO, Samantha
– fullname: HOOD, Sarah Carol
– fullname: SWETT, Rebecca Jane
– fullname: NUHANT, Philippe Marcel
– fullname: SHI, Yi
– fullname: SHRESTHA, Muna
– fullname: MAXWELL, Brad
– fullname: BOUCHER, Diane
– fullname: SPOSATO, Marisa
– fullname: GREY JR., Ronald Lee
– fullname: BRODNEY, Michael Aaron
– fullname: MEDEK, Ales
– fullname: BLIGH, Cavan McKeon
– fullname: OVERHOFF, Kirk Alan
– fullname: HURLEY, Dennis James
– fullname: CLARK, Michael Philip
– fullname: MAXWELL, John Patrick
– fullname: DAMAGNEZ, Veronique
– fullname: XU, Jinwang
– fullname: FIMOGNARI, Robert Francis
– fullname: LAI, Mei-Hsiu
– fullname: BANDARAGE, Upul Keerthi
– fullname: HALL, Amy Beth
– fullname: TAPLEY, Timothy Lewis
– fullname: ROEPER, Stefanie
– fullname: LIU, Siying
– fullname: GIROUX, Simon
– fullname: TANG, Qing
BookMark eNrjYmDJy89L5WSwc_b3c3H1C3Z1UQgJinT2dPbxdFYIiAwK8vdxDVZwBCKfAA9HXUMFR78QT6CKgGBPPwVff5dQH8cQ_6BgHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oSH-5vZACEJuaGZgaOhsbEqQIANdctAw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate PYRROLES TRICYCLIQUES CONDENSÉS UTILISÉS COMME MODULATEURS DE L'ALPHA-1 ANTITRYPSINE
ExternalDocumentID WO2020247160A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2020247160A13
IEDL.DBID EVB
IngestDate Fri Oct 18 06:06:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2020247160A13
Notes Application Number: WO2020US32832
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201210&DB=EPODOC&CC=WO&NR=2020247160A1
ParticipantIDs epo_espacenet_WO2020247160A1
PublicationCentury 2000
PublicationDate 20201210
PublicationDateYYYYMMDD 2020-12-10
PublicationDate_xml – month: 12
  year: 2020
  text: 20201210
  day: 10
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies VERTEX PHARMACEUTICALS INCORPORATED
RelatedCompanies_xml – name: VERTEX PHARMACEUTICALS INCORPORATED
Score 3.3014154
Snippet The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I), tautomers thereof, pharmaceutically...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CONDENSED TRYCICLIC PYRROLES AS ALPHA-1 ANTITRYPSIN MODULATORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201210&DB=EPODOC&locale=&CC=WO&NR=2020247160A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMIwp6ptOxY8pBaVvxXT9Wh6mdEnHKl1T2k63p9F0GQjSDVfx73stm-5pkIckF45Lwt3lkrsLQo-OYWQ406W2ILmlmQTnGunKBWzIHOtzKQ1iVbHDo9Aejs3XiTVpoM9tLEydJ_SnTo4IHJUDv5e1vF79X2Kx2rdy_SQ-oGv5Mkh7TN1Yx50qQxlWWb_nRZxxqlIKdpsaxjWsA4LYxi7YSgdwkHYqfvDe-lVcympXqQxO0WEE-IryDDVk0ULHdPv3WgsdjTZP3lDdcN_6HD1THjIvTDympPGU-jTwqRJN45gHXqK4UIJo6Gq64oapDyOixA-VEWfjwE15nFygh4GX0qEGhMz-5j1757tUG5eoWSwLeYWUjjAz4ZBMCNs2wQIRXSFtkzhYz52MGMY1au_DdLMffItOqmbls6HjNmqWX9_yDjRvKe7rBfsF4AyAzA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWlb8V07dr1YUqXdrTaL9pOt6fRdBkI0g1X8d_3Wjb1aZCHkAtHPri7_JK7C8C9rigZyWQuLYy8J6kGySWjzxe4IXMizzlXjF4VO-wHmjNWnye9SQM-trEwdZ7Q7zo5IkpUjvJe1vp69XeJZdW-lesH9o5Ny6dROrDEDTruVhnKiGgNB3YUWiEVKUXcJgZxTeuiItaIiVhpDw_ZeiUP9uuwiktZ_TcqoyPYj5BfUR5DgxdtaNHt32ttOPA3T95Y3Ujf-gQeaRhYdpDYlpDGU-pSz6VCNI3j0LMTwcTiRY4pyYIZpC72iBI3EPzQGntmGsbJKdyN7JQ6Eg5k9jvv2Vv4f9TKGTSLZcHPQegyNWO6kTGmaSoiENZnXFMNnci5nhmKcgGdXZwud5NvoeWkvjfz3ODlCg4rUuW_IZMONMvPL36NVrhkN_Xi_QAWrIO_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CONDENSED+TRYCICLIC+PYRROLES+AS+ALPHA-1+ANTITRYPSIN+MODULATORS&rft.inventor=GAGNON%2C+Kevin+James&rft.inventor=LOOKER%2C+Adam&rft.inventor=BOYD%2C+Michael+John&rft.inventor=ZAKY%2C+Mariam&rft.inventor=GARCIA+BARRANTES%2C+Pedro+Manuel&rft.inventor=FLEMING%2C+Gabrielle+Simone&rft.inventor=RODAY%2C+Setu&rft.inventor=GIACOMETTI%2C+Robert+Daniel&rft.inventor=JOHNSON%2C+JR&rft.inventor=FANNING%2C+Lev+Tyler+Dewey&rft.inventor=RONKIN%2C+Steven+M&rft.inventor=STAVROPOULOS%2C+Kathy&rft.inventor=KESAVAN%2C+Sarathy&rft.inventor=THOMSON%2C+Stephen&rft.inventor=JONES%2C+Peter&rft.inventor=SAWANT%2C+Rupa&rft.inventor=GUIDO%2C+Samantha&rft.inventor=HOOD%2C+Sarah+Carol&rft.inventor=SWETT%2C+Rebecca+Jane&rft.inventor=NUHANT%2C+Philippe+Marcel&rft.inventor=SHI%2C+Yi&rft.inventor=SHRESTHA%2C+Muna&rft.inventor=MAXWELL%2C+Brad&rft.inventor=BOUCHER%2C+Diane&rft.inventor=SPOSATO%2C+Marisa&rft.inventor=GREY+JR.%2C+Ronald+Lee&rft.inventor=BRODNEY%2C+Michael+Aaron&rft.inventor=MEDEK%2C+Ales&rft.inventor=BLIGH%2C+Cavan+McKeon&rft.inventor=OVERHOFF%2C+Kirk+Alan&rft.inventor=HURLEY%2C+Dennis+James&rft.inventor=CLARK%2C+Michael+Philip&rft.inventor=MAXWELL%2C+John+Patrick&rft.inventor=DAMAGNEZ%2C+Veronique&rft.inventor=XU%2C+Jinwang&rft.inventor=FIMOGNARI%2C+Robert+Francis&rft.inventor=LAI%2C+Mei-Hsiu&rft.inventor=BANDARAGE%2C+Upul+Keerthi&rft.inventor=HALL%2C+Amy+Beth&rft.inventor=TAPLEY%2C+Timothy+Lewis&rft.inventor=ROEPER%2C+Stefanie&rft.inventor=LIU%2C+Siying&rft.inventor=GIROUX%2C+Simon&rft.inventor=TANG%2C+Qing&rft.date=2020-12-10&rft.externalDBID=A1&rft.externalDocID=WO2020247160A1